Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2024 Earnings Call Transcript February 12, 2025
Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.98, expectations were $-1.
Operator: Good morning, ladies and gentlemen, and welcome to the Mineralys Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all lines are in a listen-only mode. [Operator Instructions] Also note that, this call is being recorded on Wednesday, February, 12, 2025. Now I...
